[EN] 5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE [FR] COMPOSÉS HÉTÉROARYLES À 5 CHAÎNONS CONTENANT UNE FRACTION HYDROXAMATE ET LEUR UTILISATION
[EN] POTENT AND SELECTIVE INHIBITORS OF THE CALCIUM-ACTIVATED POTASSIUM CHANNEL, KCa3.1, FOR USE AS PLATFORM THERAPEUTICS<br/>[FR] INHIBITEURS PUISSANTS ET SÉLECTIFS DE CANAUX POTASSIQUES ACTIVÉS PAR LE CALCIUM KCA3.1, DESTINÉS À ÊTRE UTILISÉS COMME PLATE-FORMES THÉRAPEUTIQUES
申请人:UNIV NANYANG TECH
公开号:WO2022115043A1
公开(公告)日:2022-06-02
Provided is the use of compounds of Formula I, as well as certain specific compounds, or a pharmaceutically acceptable salt, solvate or derivative thereof, in the preparation of a medicament to treat or prevent a disease condition that is associated with increased KCa3.1 or altered activity, such as stroke.
Simple and facile method for the preparation of vinyl azides
作者:Vikas N. Telvekar、Balaram S. Takale、Harshal M. Bachhav
DOI:10.1016/j.tetlet.2009.06.097
日期:2009.9
A synthetic utility of [bis(trifluoroacetoxy)iodo]benzene on α,β-unsaturated carboxylicacid is described. This is the first example of preparation of vinyl azide using α,β-unsaturated carboxylicacids directly by using hypervalent iodine reagent. The advantage of this protocol is characterized with non-toxicity of starting material and shorter reaction times to obtain good preparative yields. The
[EN] 5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE<br/>[FR] COMPOSÉS HÉTÉROARYLES À 5 CHAÎNONS CONTENANT UNE FRACTION HYDROXAMATE ET LEUR UTILISATION
申请人:UNIV LILLE
公开号:WO2020148403A1
公开(公告)日:2020-07-23
The present invention is directed to 5-membered heteroaryl compounds containing a hydroxamate moiety of Formula I, pharmaceutically acceptable salts or solvates thereof, and their use as sensitizers for chemotherapy of malignant tumors.